openPR Logo
Press release

Allied Market Research

01-28-2020 07:26 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market

Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market

"World Castration-Resistant Prostate Cancer (CRPC) Therapeutics - Market Opportunity and Forecast, 2014-2020", the global CRPC therapeutics market would generate a revenue of $9.5 billion by 2020, registering a CAGR of 9.1% from 2015 to 2020. Hormonal therapy segment spearheads among all the therapy types, governing around 4/5th of the global market value in 2014 and would sustain its market position throughout 2020.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/694

The global CPRC therapeutics market has witnessed high growth in the past few years and would continue to grow at a consistent pace due to the high unmet clinical need associated with the disease. Large amount of drugs in pipeline, augmented patient awareness and untapped nmCRPC space would largely drive the market growth during the forecast period. On the other hand, introduction of novel treatments would be difficult as long as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) require an improvement in overall survival period. Moreover, lack of differentiation in mechanism of action among the approved and novel agents along with factors such as premium pricing and uncertain reimbursement policies would hinder the market growth during the analysis period.

The market would gain traction in the emerging countries of Asia-Pacific and third-world countries such as Africa and Latin America. Asia Pacific and LAMEA region would collectively constitute around 1/3rd of the overall market by 2020. The large undiagnosed patient population, rapid urbanization, rising disposable income, improved government funding towards healthcare and growing awareness about prostate cancer would be the prime reasons responsible for the impressive market growth in these regions. The market growth would mainly rely on the novel breakthrough treatments with improved overall survival benefits. The survival benefit would be instrumental in governing the peak sales and market penetration of novel approved drugs.

Key findings of the study:

North America CRPC market spearheads the regional CRPC markets and would continue to lead throughout the forecast period
Radiotherapy segment is projected to grow at a CAGR of 24.5% throughout the forecast period, fastest among all CRPC therapy segments
Immunotherapy segment is expected to grow more than threefold over the forecast period
Asia Pacific CRPC market is expected to garner 1/5th of the overall market revenue by 2020
European market is expected to expand more than two-fold as compared to North American market (within hormonal therapy segment) over the forecast period
Countries like India and China holds immense future market potential as there is a higher count of undiagnosed CRPC patients.
The principal and key strategy adopted by the leading players in the market is product launch. In order to implement the strategy, acquisitions and partnerships/collaborations have been the key strategies adopted by the leading industry players. The key companies profiled in the report are Astellas Inc., Johnson & Johnson, Sanofi S.A, Dendreon Corporation, Bayer AG, and others.

To view the report, visit the website at https://www.alliedmarketresearch.com/castration-resistant-prostate-cancer-therapeutics-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Allied Market Research here

News-ID: 1911777 • Views:

More Releases from Allied Market Research

Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
The global polyisoprene industry was estimated at $21.5 billion in 2021, and is anticipated to hit $36.4 billion by 2031, registering a CAGR of 5.52% from 2022 to 2031. Rise in demand for elastomers in the automotive, industrial, footwear, and medical industries drive the growth of the global polyisoprene market. Moreover, increase in usage of polyisoprene in surgical gloves has supplemented the growth yet more. Simultaneously, several growth prospects in the developing and developed economies have also been
Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
The global polyisoprene industry was estimated at $21.5 billion in 2021, and is anticipated to hit $36.4 billion by 2031, registering a CAGR of 5.52% from 2022 to 2031. Rise in demand for elastomers in the automotive, industrial, footwear, and medical industries drive the growth of the global polyisoprene market. Moreover, increase in usage of polyisoprene in surgical gloves has supplemented the growth yet more. Simultaneously, several growth prospects in the developing and developed economies have also been
Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
The global polyisoprene industry was estimated at $21.5 billion in 2021, and is anticipated to hit $36.4 billion by 2031, registering a CAGR of 5.52% from 2022 to 2031. Rise in demand for elastomers in the automotive, industrial, footwear, and medical industries drive the growth of the global polyisoprene market. Moreover, increase in usage of polyisoprene in surgical gloves has supplemented the growth yet more. Simultaneously, several growth prospects in the developing and developed economies have also been
Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
The global polyisoprene industry was estimated at $21.5 billion in 2021, and is anticipated to hit $36.4 billion by 2031, registering a CAGR of 5.52% from 2022 to 2031. Rise in demand for elastomers in the automotive, industrial, footwear, and medical industries drive the growth of the global polyisoprene market. Moreover, increase in usage of polyisoprene in surgical gloves has supplemented the growth yet more. Simultaneously, several growth prospects in the developing and developed economies have also been

All 5 Releases


More Releases for CRPC

(2022-2028) Castration-Resistant Prostate Cancer (CRPC) /HRPCA Therapeutics Mark …
The Castration-Resistant Prostate Cancer (CRPC) /HRPCA Therapeutics report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research. The Castration-Resistant Prostate Cancer (CRPC)
Understanding COVID-19’s impact on the Castration-Resistant Prostate Cancer (C …
Global CRPC therapeutics market would generate a revenue of $9.5 billion by 2020, registering a CAGR of 9.1% from 2015 to 2020. Hormonal therapy segment spearheads among all the therapy types, governing around 4/5th of the global market value in 2014 and would sustain its market position throughout 2020. Download free sample Report @ alliedmarketresearch.com/request-sample/694 The global CPRC therapeutics market has witnessed high growth in the past few years and would continue
Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Siz …
Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining prominence in the prostate cancer market. The global CRPC market is poised to expand at a significant pace, owing to high unmet clinical need, limited survival benefits, growing prevalence rates and fast emerging treatment modifications. The market growth would pivot around the novel breakthrough
Castration-Resistant Prostate Cancer (CRPC) Treatment Market- Evolving Manufactu …
HTF MI published a new industry research that focuses on Castration-Resistant Prostate Cancer (CRPC) Treatment market and delivers in-depth market analysis and future prospects of Global Castration-Resistant Prostate Cancer (CRPC) Treatment market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers
Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Research Rep …
The report entitled Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market : Size, Trends & Forecasts (2017-2021), provides analysis of the Global Castration-Resistant Prostate Cancer (CRPC) Treatment, with detailed analysis of market size and growth, and segmentation of the industry. The analysis includes the market by value, by segments, by application and by region. The report also provides the analysis of the Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market of
Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Res …
This report studies Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Astellas Johnson & Johnson Sanofi Dendreon Bayer To Get Sample Copy of Report visit @ http://www.qyresearchreports.com/sample/sample.php?rep_id=905816&type=E Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth